Researchers from Kessler Foundation and Kessler Institute for Rehabilitation (collectively termed “Kessler”) have conducted the first prospective study to assess whether transcutaneous spinal stimulation (TSS) interacts with implanted intrathecal baclofen (ITB) pump delivery systems for managing spasticity. Their article, “Transcutaneous spinal stimulation in patients with intrathecal baclofen pump delivery system: A preliminary safety study,” was published December 21, 2022, in Frontiers in Neuroscience.
Leave A Comment